JEFFS ROGER — SEC insider filings

SEC reporting owner CIK 1231615. 59 insider filings on record with FilingPulse; latest filed 2026-10-13.

Transaction summary — filings shown

Covers the 50 most recent of 59 filings on record, filed 2022-03-08 to 2026-10-13. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Liquidia Corp (LQDA)Chief Executive Officer, Director354 legs · 212,478 sh · $1,347,67337 legs · 848,244 sh · $34,973,82439
Axsome Therapeutics, Inc. (AXSM)Director15—11 legs · 143,053 sh · $15,772,94818

Insider filings — JEFFS ROGER

FiledFormIssuerReported transactionsSource
2026-10-134Liquidia Corp (LQDA)Option exercise (M): 13,833 · Option exercise (M): 14,333 · Sale (S): 32,744 @ $28.48 · Option exercise (M): 13,833 (derivative) @ $0 · Option exercise (M): 14,333 (derivative) @ $0EDGAR
2026-07-144Liquidia Corp (LQDA)Option exercise (M): 13,834 · Option exercise (M): 14,333 · Sale (S): 2,505 @ $71.39 · Sale (S): 32,744 @ $71.52 · Option exercise (M): 13,834 (derivative) @ $0 · Option exercise (M): 14,333 (derivative) @ $0EDGAR
2026-06-114Axsome Therapeutics, Inc. (AXSM)Sale (S): 286 @ $246.18 · Sale (S): 286 @ $249.12EDGAR
2026-06-104Axsome Therapeutics, Inc. (AXSM)Option exercise (M): 1,429 · Option exercise (M): 1,429 (derivative) @ $0EDGAR
2026-06-094Axsome Therapeutics, Inc. (AXSM)Grant/award (A): 1,721 (derivative) @ $0EDGAR
2026-05-284Liquidia Corp (LQDA)Sale (S): 6,428 @ $62.18EDGAR
2026-05-264Liquidia Corp (LQDA)Sale (S): 25,000 @ $61.13 · Sale (S): 25,000 @ $61.52 · Sale (S): 25,000 @ $60.38EDGAR
2026-05-204Liquidia Corp (LQDA)Sale (S): 25,000 @ $56.77 · Sale (S): 25,000 @ $58.65 · Sale (S): 25,000 @ $61.30EDGAR
2026-05-154Liquidia Corp (LQDA)Sale (S): 25,000 @ $56.29 · Sale (S): 25,000 @ $58.62 · Sale (S): 25,000 @ $57.04EDGAR
2026-05-124Liquidia Corp (LQDA)Sale (S): 25,000 @ $42.14 · Sale (S): 25,000 @ $41.50 · Sale (S): 25,000 @ $54.04EDGAR
2026-05-074Liquidia Corp (LQDA)Sale (S): 25,000 @ $40.10 · Sale (S): 25,000 @ $40.78 · Sale (S): 25,000 @ $42.09EDGAR
2026-04-214Liquidia Corp (LQDA)Sale (S): 18,839 @ $40.60EDGAR
2026-04-164Liquidia Corp (LQDA)Sale (S): 3,300 @ $40 · Sale (S): 25,000 @ $40.14 · Sale (S): 25,000 @ $40.31EDGAR
2026-04-144Liquidia Corp (LQDA)Option exercise (M): 13,834 · Option exercise (M): 14,333 · Sale (S): 32,744 @ $38.37 · Sale (S): 21,433 @ $40.12 · Option exercise (M): 13,834 (derivative) @ $0 · Option exercise (M): 14,333 (derivative) @ $0EDGAR
2026-04-134Liquidia Corp (LQDA)Sale (S): 25,000 @ $40.12EDGAR
2026-01-214Liquidia Corp (LQDA)Grant/award (A): 115,344 @ $0 · Grant/award (A): 173,016 (derivative) @ $0EDGAR
2026-01-134Liquidia Corp (LQDA)Option exercise (M): 13,833 · Option exercise (M): 57,332 · Sale (S): 66,610 @ $37.43 · Option exercise (M): 13,833 (derivative) @ $0 · Option exercise (M): 57,332 (derivative) @ $0EDGAR
2025-10-154Liquidia Corp (LQDA)Option exercise (M): 13,834 · Sale (S): 20,261 @ $23.41 · Option exercise (M): 13,834 (derivative) @ $0EDGAR
2025-09-024Axsome Therapeutics, Inc. (AXSM)Sale (S): 13,464 @ $123.68EDGAR
2025-08-294Axsome Therapeutics, Inc. (AXSM)Sale (S): 20,000 @ $122.30 · Sale (S): 20,000 @ $121.60 · Sale (S): 20,000 @ $121.27EDGAR
2025-08-264Axsome Therapeutics, Inc. (AXSM)Sale (S): 16,694 @ $120.08 · Sale (S): 20,000 @ $120.03EDGAR
2025-07-154Liquidia Corp (LQDA)Option exercise (M): 13,833 · Sale (S): 20,252 @ $14.28 · Option exercise (M): 13,833 (derivative) @ $0EDGAR
2025-07-154Liquidia Corp (LQDA)Option exercise (M): 13,833 · Sale (S): 20,252 @ $14.28 · Option exercise (M): 13,833 (derivative) @ $0EDGAR
2025-06-104Axsome Therapeutics, Inc. (AXSM)Grant/award (A): 3,166 (derivative) @ $0 · Grant/award (A): 1,429 (derivative) @ $0EDGAR
2025-06-054Liquidia Corp (LQDA)Option exercise (M): 69,169 · Sale (S): 30,610 @ $16.97 · Option exercise (M): 69,169 (derivative) @ $0EDGAR
2025-04-164Liquidia Corp (LQDA)Sale (S): 14,130 @ $13.57EDGAR
2025-02-254Axsome Therapeutics, Inc. (AXSM)Grant/award (A): 1,408 (derivative) @ $0EDGAR
2025-01-144Liquidia Corp (LQDA)Grant/award (A): 229,327 @ $0 · Sale (S): 22,343 @ $11.78 · Grant/award (A): 229,327 (derivative) @ $0EDGAR
2024-10-154Liquidia Corp (LQDA)Sale (S): 8,053 @ $11.11EDGAR
2024-07-154Liquidia Corp (LQDA)Sale (S): 8,053 @ $12.53EDGAR
2024-06-114Axsome Therapeutics, Inc. (AXSM)Grant/award (A): 5,799 (derivative) @ $0EDGAR
2024-04-164Liquidia Corp (LQDA)Sale (S): 8,360 @ $14.58EDGAR
2024-03-194Liquidia Corp (LQDA)Sale (S): 28,583 @ $15.82EDGAR
2024-03-154Axsome Therapeutics, Inc. (AXSM)Option exercise (M): 13,000 @ $22.03 · Sale (S): 13,000 @ $69.70 · Option exercise (M): 16,976 @ $25.53 · Sale (S): 16,976 @ $69.70 · Option exercise (M): 2,347 @ $29.91 · Sale (S): 2,347 @ $71.61 · +3 moreEDGAR
2024-02-294Axsome Therapeutics, Inc. (AXSM)Grant/award (A): 1,425 (derivative) @ $0EDGAR
2024-01-164Liquidia Corp (LQDA)Grant/award (A): 221,338 @ $0 · Grant/award (A): 221,338 (derivative) @ $0EDGAR
2023-12-184Liquidia Corp (LQDA)Purchase (P): 139,665 @ $7.16EDGAR
2023-06-064Axsome Therapeutics, Inc. (AXSM)Grant/award (A): 5,681 (derivative) @ $0EDGAR
2023-04-104/ALiquidia Corp (LQDA)Grant/award (A): 993 @ $4.90EDGAR
2023-03-064Axsome Therapeutics, Inc. (AXSM)Grant/award (A): 2,082 (derivative) @ $0EDGAR
2023-01-134Liquidia Corp (LQDA)Grant/award (A): 289,500 @ $0 · Grant/award (A): 371,154 (derivative) @ $0EDGAR
2023-01-054Liquidia Corp (LQDA)Option exercise (M): 15,807 · Option exercise (M): 15,807 (derivative) @ $0EDGAR
2022-10-044Liquidia Corp (LQDA)Option exercise (M): 47,423 · Option exercise (M): 47,423 (derivative) @ $0EDGAR
2022-09-074Liquidia Corp (LQDA)Purchase (P): 43,820 @ $5.57EDGAR
2022-09-014Liquidia Corp (LQDA)Purchase (P): 993 @ $4.90EDGAR
2022-06-224Liquidia Corp (LQDA)Grant/award (A): 931,475 (derivative) @ $0EDGAR
2022-06-074Axsome Therapeutics, Inc. (AXSM)Grant/award (A): 16,976 (derivative) @ $0EDGAR
2022-05-254Liquidia Corp (LQDA)Purchase (P): 28,000 @ $3.53EDGAR
2022-04-204Liquidia Corp (LQDA)Grant/award (A): 154,167 @ $0EDGAR
2022-03-084Axsome Therapeutics, Inc. (AXSM)Grant/award (A): 2,347 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-11-18 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1231615 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs